A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

Bibliographic Details
Main Authors: Tandon, Rajiv, Cucchiaro, Josephine, Phillips, Debra, Hernandez, David, Mao, Yongcai, Pikalov, Andrei, Loebel, Antony
Format: Online
Language:English
Published: SAGE Publications 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717319/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717319/

Similar Items